Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
15/05/2024 | 14:42 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:GHSI | Guardion Health Sciences Inc |
15/05/2024 | 14:39 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:GHSI | Guardion Health Sciences Inc |
13/05/2024 | 23:01 | GlobeNewswire Inc. | Guardion Health Sciences Announces | NASDAQ:GHSI | Guardion Health Sciences Inc |
13/05/2024 | 22:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:GHSI | Guardion Health Sciences Inc |
06/05/2024 | 22:01 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:GHSI | Guardion Health Sciences Inc |
06/05/2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:GHSI | Guardion Health Sciences Inc |
29/03/2024 | 11:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
06/02/2024 | 16:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:GHSI | Guardion Health Sciences Inc |
31/01/2024 | 23:21 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:GHSI | Guardion Health Sciences Inc |
31/01/2024 | 00:13 | GlobeNewswire Inc. | Guardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc. | NASDAQ:GHSI | Guardion Health Sciences Inc |
13/11/2023 | 22:10 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
14/08/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
08/08/2023 | 02:47 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:GHSI | Guardion Health Sciences Inc |
05/07/2023 | 23:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:GHSI | Guardion Health Sciences Inc |
16/06/2023 | 23:02 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:GHSI | Guardion Health Sciences Inc |
05/06/2023 | 23:09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:GHSI | Guardion Health Sciences Inc |
30/05/2023 | 14:00 | GlobeNewswire Inc. | Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer | NASDAQ:GHSI | Guardion Health Sciences Inc |
15/05/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
15/05/2023 | 14:01 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:GHSI | Guardion Health Sciences Inc |
17/04/2023 | 14:15 | GlobeNewswire Inc. | Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022 | NASDAQ:GHSI | Guardion Health Sciences Inc |
17/04/2023 | 14:01 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:GHSI | Guardion Health Sciences Inc |
06/03/2023 | 14:00 | GlobeNewswire Inc. | Guardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder Value | NASDAQ:GHSI | Guardion Health Sciences Inc |
08/02/2023 | 21:05 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:GHSI | Guardion Health Sciences Inc |
24/01/2023 | 22:05 | GlobeNewswire Inc. | Guardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing Requirements | NASDAQ:GHSI | Guardion Health Sciences Inc |
11/01/2023 | 23:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GHSI | Guardion Health Sciences Inc |
06/01/2023 | 22:15 | GlobeNewswire Inc. | Guardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023 | NASDAQ:GHSI | Guardion Health Sciences Inc |
12/12/2022 | 23:16 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:GHSI | Guardion Health Sciences Inc |
02/12/2022 | 23:08 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:GHSI | Guardion Health Sciences Inc |
29/11/2022 | 23:06 | GlobeNewswire Inc. | Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock | NASDAQ:GHSI | Guardion Health Sciences Inc |
16/11/2022 | 13:35 | TipRanks | Maxim Group Sticks to Its Buy Rating for Guardion Health Sciences (GHSI) | NASDAQ:GHSI | Guardion Health Sciences Inc |